Chief Researcher at the Chumakov Institute, Academician of the Russian Academy of Sciences, Professor Alexei Egorov said that the main difference between the developed vaccine against the new coronavirus from its analogues is its composition. RIA Novosti.
“The main difference of this vaccine is that it is not made from individual coronavirus antigens, but from a whole inactivated virus. Therefore, it gives a complete set of all antigens of this virus, and this gives a complete set of all antibodies, ”said Yegorov.
The specialist noted that thanks to this, the drug will be able to give the body the broadest protection against coronavirus infection.
The new vaccine will be tentatively ready in February.
Recall, the Ministry of Health of the Russian Federation registered the world’s first vaccine to prevent COVID-19 in August. It was developed at the Gamaleya Research Center for Electrochemistry. Over 50 countries of the world interested in buying about a billion doses of this drug.
Formerly director of the National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya of the Ministry of Health of the Russian Federation Alexander Gintsburg statedthat the mass vaccination with Sputnik V could begin in January-February 2021.
– .
